Navigation Links
Melanoma Rates on the Rise in U.S.
Date:1/8/2009

Increase could indicate an epidemic of skin cancer, researchers suggest

THURSDAY, Jan. 8 (HealthDay News) -- New cases of the deadly skin cancer melanoma are increasing among men and women in the United States, particularly among older men, researchers report.

Whether the increase in melanoma signals an epidemic is a matter of debate. However, the rate is increasing among all Americans and cannot be due to better screening alone, the researchers contend.

"Melanoma rates are still going up, especially among older white men," said lead researcher Dr. Eleni Linos, from the dermatology department at Stanford University Medical Center. "This calls for greater awareness for patients, their families and physicians."

The report is published in the January issue of the Journal of Investigative Dermatology.

For the study, Linos's team used data from the Surveillance Epidemiology and End Results (SEER) program to identify new cases of melanoma between 1992 and 2004. During that period, 70,596 cases of melanoma were diagnosed among non-Hispanic whites in the United States.

Rates of melanoma increased by 3.1 percent a year, the researchers found. The increased rate was for all types of melanoma and for all thicknesses of tumors. Moreover, the rate of melanoma doubled in all socioeconomic groups, while deaths from the disease did not increase significantly.

"Scientists have debated whether the rising statistics for melanoma are skewed, as doctors detect more benign cancers earlier through screening," Linos said.

Melanoma rates are going up among all socioeconomic groups, which is a marker for access to physician care, and across all levels of tumor thickness, which is a marker of severity of this disease, Linos noted. Among men age 65 and older, the rates of melanoma have reached more than 125 cases per 100,000 men.

"Because the incidence has gone up for both men and wom
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Melanoma Diagnosis Often Delayed for Rural Poor
2. Melanoma drug revs immune cells but cancer cells ignore it
3. Promising drug combination may help those with ocular melanoma that has spread
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
6. New type of drug shows promise in attacking melanoma in an innovative way
7. Genes Unlock New Treatments for Deadly Melanoma
8. Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
9. Researchers Hone in on Cancer Stem Cells for Melanoma
10. Melanomas may appear noticeably different than other moles
11. Melanomas Present Unique Appearance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Melanoma Rates on the Rise in U.S. 
Melanoma Rates on the Rise in U.S.
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Sickle cell ... red blood cells, is one of the most ... around the world, including more than 70,000 Americans.(1) ... of the American Society of Hematology highlights intriguing ... pandemic presents for children with this blood disorder, ...
(Date:12/6/2009)... Joseph W. Belluck of Belluck & Fox, LLP says dangerous substances ... seasons. , ... New York, NY (PRWEB) December 6, ... season, they should be alert to reports of recalls due to ... lawyer., , ,“Close to 230,000 children visit hospital emergency rooms each ...
(Date:12/5/2009)... Type of Blood Cancer Is Most Challenging-- ... oncologists have identified specific genes, dubbed partner genes, that ... of leukemia in infants. By more accurately defining specific ... may benefit from particular treatments. ,, Oncologists also ...
(Date:12/5/2009)... the launch of International Solutions, an innovative new international private medical ... equivalent. In addition to offering customers the flexibility to add or ... budgets, International Solutions enables customers to tailor their benefits to complement ... , ...
(Date:12/4/2009)... LLP employees came together in more than 90 offices nationwide ... the audit, tax and advisory firm,s support for literacy with ... firm,s long history of volunteerism. Instead of holiday parties, our ... holidays for some children," said Tim Flynn, Chairman of KPMG. ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
... Dec. 4, 2007 The High School Musical Rockerz Jammin ... be what kids want most this holiday season, but if ... are used, a season of joy might turn into a ... measuring the loudness of many desired toys, University of California, ...
... In response to the growing body of research ... for Cancer Research (AACR) announces the launch of a ... submissions of papers. This important new journal is the ... from preclinical research to clinical trials. , In the ...
... Our belief in power hierarchies is important in how ... a dissertation by Alexandra Snellman from Uppsala University that ... and ethnic discrimination in various situations. , Discrimination and ... our prejudices but are affected by other factors as ...
... idea that only vertebrates have sophisticated adaptive immune systems ... after being infected by them just once has been ... insects also have a form of immune memory that ... previously encountered. This was just one of the striking ...
... with Millions of Transactions, TAMPA, Fla., ... an,esteemed list of petitioners urging the White ... regulations which prohibit controlled drugs from being,electronically ... e-Prescribing,Controlled Substances Coalition, such regulations are negatively ...
... Make Life Easier for Double Amputee, MEDIA ADVISORY ... Thomas Graham, 24, recent Iraqi War Veteran and,double amputee, ... Baltimore,location, WHAT: The delivery of a special birthday ... of both legs while deployed in Iraq,nothing is deterring ...
Other Medicine News:Health News:Greater parental guidance suggested for noisy toy use 2Health News:AACR introduces Cancer Prevention Research 2Health News:AACR introduces Cancer Prevention Research 3Health News:Ethnic discrimination not only based on prejudice 2Health News:Violent sex acts boost insect's immunity system 2Health News:Violent sex acts boost insect's immunity system 3Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 2Health News:Sage Software Joins e-Prescribing Coalition for Presidential Petition 3
(Date:12/4/2009)... 4 PharmAthene, Inc. (NYSE Amex: PIP ... biological and chemical threats, announced today that the ... the effectiveness of Valortim® in an inhalation anthrax ... The data are being presented during an ...
(Date:12/4/2009)... 4 Axsun Technologies, Inc., a wholly-owned subsidiary of ... initial development and successful testing of a novel integrated ... this proprietary optical engine design raises the bar on ... for swept source OCT light sources. This approach ...
(Date:12/4/2009)... 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ... that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market its 8mg ramelteon ... by Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon ...
Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 1Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 2Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 3Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 4Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 5Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference 4725 6Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchjointpain com 51730 1Board Certified Cardiologist Dr Stephen Sinatra Featured on Searchjointpain com 51730 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 1Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 3Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 4
... MKC-1 Akt-mTOR Inhibitor Mechanism, ROCKVILLE, Md., ... ), a clinical-stage pharmaceutical company developing,therapeutics for ... today,announced the presentation of results for its ... carcinoma (RCC) models. The results were,presented at ...
... Significant Efficacy Within One ... Week of Daily ... Nasdaq:,SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today,announced the ... Hyperactivity Disorder (ADHD) experienced significant,improvements in ADHD symptom control within ...
Other Medicine Technology:EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 2EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 3EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 4Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 2Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 3Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 4Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 5Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: